Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Hospitalist

According to studies presented at the American Urological Association meeting, men with higher cholesterol levels had more than a two-fold greater risk of biochemical relapse after radical prostatectomy compared with men who had lower cholesterol levels....
As presented at ASCO, second-line bevacizumab (Avastin) as monotherapy has been associated with a 28% response rate and an overall survival edge for refractory glioblastoma. Also presented at the ASCO meeting, adding oxaliplatin (Eloxatin) to a standard...
Joseph Schoepf, M.D., Associate Professor of Radiology and Cardiology, Director of Computed Tomography Research, Medical University of South Carolina, discusses the advantages of using CTA. References and Resources Roberts WT, Bax JJ, Davies...